Tolerance to μ-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5'-O-(3-[35S]-thio)triphosphate binding

British Journal of Pharmacology

Volumn 121, Issue 7, 1997, Pages 1422-1428

  Elliott, Jackie ^b   Guo, Li ^b   Traynor, John R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

opioid receptor agonists; 35S GTP S binding; DAMGO; Morphine; SH SY5Y cells; Tolerance

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE ANTAGONIST; PENTAZOCINE; SULFUR 35;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG TOLERANCE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MORPHINE; NEUROBLASTOMA; RECEPTORS, OPIOID, MU; TUMOR CELLS, CULTURED;

EID: 0030751574     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701253     Document Type: Article

References (39)

1. ADAMS, J. & HOLTZMAN, S.R. (1990). Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacology, 100, 451-458.
2. ALOYO, V.J. (1995). Modulation of mu opioid binding by protein kinase inhibitors. Biochem. Pharmacol. 49, 17-21.
3. CARROLL, J.A., SHAW, J.S. & WICKENDEN, A.D. (1988). The physiological relevance of low agonist affinity binding at opioid μ-receptors. Br. J. Pharmacol., 94, 625-631.
4. CARTER, B.D. & MEDZIHRADSKY, F. (1992). Opioid signal transduction in intact and fragmented SH-SY5Y neural cells. J. Neurochem., 58, 1611-1619.
5. CARTER, B.D. & MEDZIHRADSKY, F. (1993a). Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol. Pharmacol., 43, 465-413.
6. CARTER, B.D. & MEDZIHRADSKY, F. (1993b). Go mediates the coupling of μ opioid receptor adenylyl cyclase in cloned neural cells and brain. Proc. Natl. Acad. Sci. U.S.A., 90, 4062-4066.
7. 3 opioid receptors in the SH-SY5Y human neuroblastoma cell line. J. Neurochem., 65, 170-175.
8. CHENG, Y.C. & PRUSSOFF, W.H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymic reaction. Biochem. Pharmacol., 22, 3099-3108.
9. CHIDIAC, P., NOUET, S. & BOUVIER, M. (1996). Agonist-induced modulation of inverse agonist efficacy at the β2-adrenergic receptor. Mol. Pharmacol., 50, 662-669.
10. CHILDERS, S.R. (1991). Opioid-receptor coupled 2nd messenger systems. Life Sci., 48, 1991-2002.
11. CHRISTIE, M.J., WILLIAMS, J.T. & NORTH, R.A. (1987). Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol., 32, 633-638.
12. ELLIOTT, J., LAMBERT, D.G., SMART, D. & TRAYNOR, J.R. (1994). Characterisation of μ-opioid receptors on SH-SY5Y cells using naloxonazine and β-funaltrexamine. Eur. J. Pharmacol. Mol. Pharmacol., 268, 447-450.
13. 35S]GTPγS binding in SH-SY5Y human neuroblastoma cells as a model for the study of opioid tolerance. Regul. Peptides, 54, 91-92.
14. HIDAKA, H., INAGAKI, M., KAWAMOTO, S. & SASAKI, Y. (1984). Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent kinase and protein kinase C. Biochemistry, 23, 5036-5041.
15. KAZMI, S.M. & MISHRA, R.K. (1987). Comparative pharmacological properties and functional coupling of μ and δ opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 32, 109-118.
16. KENNEDY, C. & HENDERSON, G. (1991). μ-Opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro. Mol. Pharmacol., 40, 1000-1005.
17. KENAKIN, T. (1993). Pharmacologic Analysis of Drug-Receptor Interactions. 2nd edition, pp 249-277. New York: Raven Press.
18. 2-adrenoceptors on SH-SY5Y human neuroblastoma cells. Eur. J. Pharmacol., 227, 19-24.
19. LAUGWITZ, K.-H., OFFERMANNS, S., SPICHER, K. & SCHULTZ, G. (1993). μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron, 10, 233-242.
20. LOWRY, O.H., ROSENBERG, N.G., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 139, 265-275.
21. 2 adrenergic receptor desensitization. Soc. Neurosci Abs., 19, 181.5.
22. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: a versatile computerised approach for characterisation of ligand-binding systems. Anal. Biochem., 107, 220-239.
23. NESTLER, E.J. (1993). Cellular responses to chronic treatment with drugs of abuse. Critical Rev. Neurobiol., 7, 23-39.
24. PAK, Y., KOUVELAS, A., SCHEIDELER, M.A., RASMUSSEN, J., O'DOWD, B.F. & GEORGE, S.R. (1996). Agonist-induced functional desensitization of the μ-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Mol. Pharmacol. 50, 1214-1222.
25. PEI, G., KEIFFER, B.L., LEFKOWITZ, R.J. & FREEDMAN, N.J. (1995). Agonist-dependent phosphorylation of the mouse δ-opioid receptor: involvement of G-protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol., 48, 173-177.
26. PRATHER, P.L., TSAI, A.W., & LAW, P.Y. (1994). Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma cell SH-SY5Y cells. J. Pharmacol. Exp. Ther., 270, 177-184.
27. PUTTFARCKEN, P.S., WERLING, L.L. & COX, B.M. (1988). Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at μ opioid receptors. Mol. Pharmacol., 33, 520-527.
28. RAYNOR, K., KONG, H., HINES, J., KONG, G., BENOVIC, J., YASUDA, K., BELL, G. & REISINE, T. (1994). Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J. Pharmacol. Exp. Ther., 270, 1381-1386.
29. SCHILLER, P.W., NGUYEN, T.M.D., WELTOWSKA, G., WILKES, B.C., MARSDEN, B.C., LEMIEUX, C. & CHUNG, N.N. (1992). Differential stereochemical requirements of μ versus δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists. Proc. Natl. Acad. Sci. U.S.A., 89, 11871-11875.
30. TRAYNOR, J.R. (1994). Opioid receptors and their subtypes: Focus on peripheral isolated tissue preparations. Neurochem. Int., 24, 427-432.
31. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 47, 848-854.
32. 3H]Diprenorphine binding to kappa-sites in guinea-pig and rat brain: evidence for apparent heterogeneity. J. Neurochem., 53, 173-178.
33. i1-phospholipase C activation in xenopus oocytes. J. Neurosci., 15, 7485-7499.
34. UHL, G.R., CHILDERS, S. & PASTERNAK, G.W. (1993). An opiate-receptor gene family reunion. Trends Pharmacol. Sci., 17, 89-93.
35. VAN VLIET, B., VAN RIJSWIJK, A.L.C.T., WARDEH, G., MULDER, A.H. & SCHOFFELMEER, A.N.M. (1993). Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons. Eur. J. Pharmacol., 245, 23-29.
36. WANG, Z., BILSKY, E.J., PORRECA, F. & SADEE, W. (1994). Constitutive μ opioid receptor activation as a regulatory mechanisms underlying narcotic tolerance and dependence. Life Sci., 54, 339-350.
37. YU, V.C. & SADEE, W. (1988). Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J. Pharmacol. Exp. Ther., 245, 350-355.
38. ZADINA, J.E., CHANG, S.L., GE, L.-J. & KASTIN, A.J. (1993). Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J Pharmacol. Exp. Ther., 265, 254-262.
39. ZADINA, J.E., HARRISON, L.M., GE, L.-J., KASTIN. A.J. & CHANG, S.L. (1994). Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther., 270, 1086-1096.